Benlysta and Pregnancy/Breastfeeding: What You Need to Know

Understanding Benlysta's Impact on Pregnancy and Breastfeeding

Lupus is a chronic autoimmune disease that can affect various parts of the body, including the skin, joints, kidneys, brain, and other organs. For individuals with lupus, managing the condition is a lifelong journey. When it comes to pregnancy and breastfeeding, many questions arise, especially for those using medications like Benlysta (belimumab). This blog post aims to provide clear, practical information for Indian readers regarding the use of Benlysta during pregnancy and breastfeeding, drawing on available medical knowledge and emphasizing the importance of consulting healthcare professionals.

What is Benlysta?

Benlysta is a prescription medication used to treat certain types of lupus, specifically systemic lupus erythematosus (SLE) and lupus nephritis. It works by targeting a protein called B-lymphocyte stimulator (BLyS), which plays a role in the immune system's overactivity in lupus. By reducing the activity of B-cells, Benlysta helps to decrease inflammation and disease activity in lupus patients.

Benlysta and Pregnancy: Safety Concerns

The question of whether Benlysta is safe to use during pregnancy is a critical one for many women with lupus. Currently, it is not definitively known whether Benlysta is safe for use during pregnancy. This lack of definitive data means that healthcare providers must carefully weigh the potential risks and benefits for each individual patient.

Potential Risks to the Fetus

Benlysta affects the immune system. Because of this, there is a theoretical concern that it could also weaken the immune system of a developing fetus. A weakened fetal immune system could potentially make the baby more susceptible to infections after birth. However, it is crucial to understand that untreated lupus itself carries significant risks during pregnancy. These risks can include:

• Increased risk of miscarriage
• Premature birth
• Preeclampsia (a serious condition characterized by high blood pressure)
• Fetal growth restriction
• Maternal complications

Therefore, the decision to continue or stop Benlysta during pregnancy is a complex one that requires a thorough discussion with your doctor. Your doctor will consider the severity of your lupus, your overall health, and the potential risks associated with both the medication and the untreated disease.

Pregnancy Registry

To gather more information about the effects of Benlysta during pregnancy, a pregnancy registry is in place. If you become pregnant while taking Benlysta, you or your doctor can enroll you in this registry. This involves collecting data on the pregnancy and the health of the baby. This information is vital for building a better understanding of Benlysta's safety profile in pregnant individuals. You can sign up for the registry by calling 877-311-8972.

Benlysta and Breastfeeding: What We Know

Similar to pregnancy, the safety of Benlysta use while breastfeeding is not well-established. It is not known whether Benlysta passes into breast milk or what effects it might have on a breastfed infant.

Considerations for Breastfeeding Mothers

Given the uncertainty, mothers who are breastfeeding or planning to breastfeed should have a detailed conversation with their doctor. The doctor will help assess the potential risks to the infant versus the benefits of continuing Benlysta for managing the mother's lupus. In some cases, alternative lupus management strategies might be considered during breastfeeding, or the decision may be made to continue Benlysta with close monitoring of the infant.

Managing Lupus During Pregnancy and Breastfeeding

The management of lupus during pregnancy and breastfeeding requires a multidisciplinary approach. Your healthcare team, which may include your rheumatologist, obstetrician, and pediatrician, will work together to ensure the best possible outcomes for both you and your baby.

Treatment Options

Your doctor will discuss various treatment options tailored to your specific situation. This might involve:

• Continuing Benlysta under careful monitoring, if the benefits are deemed to outweigh the risks.
• Switching to a medication considered safer during pregnancy and breastfeeding, if available and appropriate for your lupus severity.
• Managing lupus flares with other treatments that are known to be safe.
• Focusing on non-pharmacological approaches such as rest, stress management, and a healthy diet.

When to Consult a Doctor

It is essential to consult your doctor before, during, and after pregnancy if you are using Benlysta or considering it. Specifically, you should speak with your doctor if:

• You are planning to become pregnant.
• You become pregnant while taking Benlysta.
• You are currently breastfeeding and taking Benlysta.
• You are considering breastfeeding while on Benlysta.
• You have any concerns or questions about Benlysta's effects on your pregnancy or your baby.

Do not make any changes to your medication regimen without consulting your healthcare provider. Your doctor is the best resource to guide you through these important decisions, ensuring your health and the well-being of your child.

Conclusion

Navigating lupus treatment during sensitive periods like pregnancy and breastfeeding can be challenging. While definitive safety data for Benlysta in these situations is still evolving, open communication with your healthcare team is paramount. By understanding the current knowledge, participating in registries, and working closely with your doctors, you can make informed decisions that prioritize both your health and the health of your baby. Remember, managing lupus effectively is key to a healthier pregnancy and a healthier future.